You are here: Industry Insights > COVID-19

News List

Viravaxx AG and Medical University of Vienna collaborate on a project for immune diagnosis and vaccination for COVID-19 expresspharma
April 22, 2020
In a clinical study, which has already received ethics approval and will start very soon, sera from convalescent COVID-19 patients will be tested for virus neutralization capacity and for epitope mapping.
KidneyIntelX to Predict Major Adverse Kidney Events in COVID-19 Patients americanpharmaceuticalreview
April 21, 2020
Renalytix announced the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19.
Aptar Requests EUA for N95 Filtering Facepiece Respirator Decontamination americanpharmaceuticalreview
April 21, 2020
AptarGroup is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows easy disinfecting of N95 filtering facepiece respirators (N95 mask).
Gattefossé Takes Measures, Continues Operations during COVID-19 Pandemic americanpharmaceuticalreview
April 21, 2020
Gattefossé is working to ensuring the protection of its employees and to manufacturing and delivering, as far as possible, its products to its customers despite the health crisis.
Novartis to Sponsor Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients americanpharmaceuticalreview
April 21, 2020
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19
Stero Biotechs Announces CBD-Steroid Treatment Trial for COVID-19 americanpharmaceuticalreview
April 21, 2020
Stero Biotechs, in a collaboration with its main partner and shareholder, Mor Research Applications announced a new clinical trial in the global efforts of fighting the COVID-19 virus.
Sir Andrew Whitty to co-lead WHO COVID-19 vaccine effort europeanpharmaceuticalreview
April 21, 2020
Whitty will take a leave of absence, effective today, to co-lead a global effort by the World Health Organization (WHO) to accelerate the development of a COVID-19 vaccine.
IND submitted for opaganib, potential COVID-19 treatment europeanpharmaceuticalreview
April 21, 2020
RedHill Biopharma has submitted its Investigational New Drug application for its drug opaganib, for the treatment of COVID-19, to the FDA.
UK national priority COVID-19 trial now recruiting patients europeanpharmaceuticalreview
April 21, 2020
The PRINCIPLE trial aims to evaluate therapeutics that could slow the progression of COVID-19 symptoms in patients most at risk of complications.
Incyte begins Phase III trial of ruxolitinib to treat Covid-19 pharmaceutical-technology
April 21, 2020
Incyte has started a Phase III clinical trial of ruxolitinib (Jakafi) to treat cytokine storm caused by Covid-19 coronavirus infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page